The dual role of dopamine and serotonin in cancer progression and inflammation: Mechanisms and therapeutic potential
- 13 December 2024
- journal article
- review article
- Published by Elsevier in Neuroscience
- Vol. 569, 184-194
Abstract
No abstract availableKeywords
Funding Information
- NIGEB
This publication has 78 references indexed in Scilit:
- Serotonin signalling in cancer: Emerging mechanisms and therapeutic opportunitiesClinical and Translational Medicine, 2024
- DRD1 suppresses cell proliferation and reduces EGFR activation and PD‐L1 expression in NSCLCMolecular Oncology, 2024
- Gene therapy for neurotransmitter‐related disordersJournal of Inherited Metabolic Disease, 2024
- Correlation between the dopaminergic system and inflammation disease: a reviewMolecular Biology Reports, 2023
- Role of neurotransmitters in immune-mediated inflammatory disorders: a crosstalk between the nervous and immune systemsNeurological Sciences, 2022
- Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative roleIUBMB Life, 2022
- Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammationsCancer Immunology, Immunotherapy, 2021
- Progesterone Attenuates Brain Inflammatory Response and Inflammation-Induced Increase in Immature Myeloid Cells in a Mouse ModelInflammation, 2021
- Serotonin/dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesia: An update2021
- Targeting the 5-HT1B/1D and 5-HT1F receptors for acute migraine treatment2020